Physicians significantly underestimated the proportion of patients with systemic sclerosis who experienced pain, with rates of 43.4% vs 96.0%.

A systematic review and meta-analysis explored the efficacy of PRP injections for chronic tendinopathy in patients who have failed conservative treatment.

Researchers evaluated the impact of upadacitinib on early pain control among patients with axial spondyloarthritis.